Eli Lilly and Company

LLY

US5324571083

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:00:22 2025-01-16 am EST			5-day change	1st Jan Change
757.46 ^USD	+1.44%		-5.52%	-2.11%

05:45am	Eli Lilly's Omvoh Receives US Approval for Crohn's Disease	MT
03:56am	Eli Lilly: FDA approves Omvoh for Crohn's disease	CF

Sector Update: Health Care Stocks Retreat Late Afternoon

December 05, 2024 at 03:51 pm EST

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Eli Lilly and Company

Eli Lilly's Omvoh Receives US Approval for Crohn's Disease	05:45am	MT
Eli Lilly: FDA approves Omvoh for Crohn's disease	03:56am	CF
Correction to Eli Lilly Receives Approval for Crohn's Treatment Article	06:15pm	DJ
Eli Lilly Receives FDA Approval for Crohn's Disease Treatment	Jan. 15	DJ
Eli Lilly Gets FDA Approval for Omvoh to Treat Crohn's Disease	Jan. 15	MT
FDA Approves Lilly's Omvoh (Mirikizumab-Mrkz) for Crohn's Disease, Expanding Its Use to the Second Major Type of Inflammatory Bowel Disease	Jan. 15	CI
Global markets live: Boeing, Pfizer, Nvidia, Goldman Sachs, Shell...	Jan. 15
Wall Street rallies on inflation and earnings bonanza	Jan. 15
Leerink Partners Adjusts Price Target on Eli Lilly to $950 From $970, Keeps Outperform Rating	Jan. 15	MT
US stocks end mixed in choppy session as inflation data eyed	Jan. 14	RE
Health Care Slides After Lilly Warning - Health Care Roundup	Jan. 14	DJ
Eli Lilly and Company Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 02:15 PM	Jan. 14
Equities Close Mostly Higher Ahead of Consumer Inflation Report	Jan. 14	MT
Dow, S&P 500 Rise Before Consumer Inflation Report	Jan. 14	MT
US Equities Markets End Mixed Tuesday After PPI Report Shows Declaration	Jan. 14	MT
Sector Update: Health Care Stocks Slide Late Afternoon	Jan. 14	MT
Equity Markets Rise Intraday After PPI Report	Jan. 14	MT
Sector Update: Health Care Stocks Fall Tuesday Afternoon	Jan. 14	MT
Jefferies Adjusts Price Target on Eli Lilly to $996 From $994	Jan. 14	MT
Sector Update: Health Care	Jan. 14	MT
Top Midday Decliners	Jan. 14	MT
US Equity Indexes Decline With Treasury Yields as Investors Weigh Easing Wholesale Price Inflation	Jan. 14	MT
Lilly forecasts weak sales of weight-loss drug, shares slump	Jan. 14	RE
Eli Lilly Tempers Fourth-Quarter, Full-Year Revenue Expectations; Shares Decline	Jan. 14	MT
Eli Lilly Shares Fall After Downbeat Q4 Revenue Guidance	Jan. 14	MT

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).

Employees

43,000

Sector

Pharmaceuticals

Calendar

2025-02-06 - Q4 2024 Earnings Release

More about the company